Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Dreyling

Showing results (91-100 of 336) with videos related to

Pageof 34
Sort By:
Leukemia & Lymphoma|May 7, 2015
Advances and issues in mantle cell lymphoma research: report of the 2014 Mantle Cell Lymphoma Consortium WorkshopBrad S Kahl, Leo I Gordon, Martin Dreyling, et al.
European Journal of Haematology|June 11, 2014
Severe cytokine release syndrome after the first dose of Brentuximab Vedotin in a patient with relapsed systemic anaplastic large cell lymphoma (sALCL): a case report and review of literatureStefan K Alig, Martin Dreyling, Bettina Seppi, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 10, 2008
A polyvalent cellular vaccine induces T-cell responses against specific self-antigens overexpressed in chronic lymphocytic B-cell leukemiaKonrad Kronenberger, Elfriede Nössner, Bernhard Frankenberger, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|August 12, 2009
Combination of hyperthermia and bortezomib results in additive killing in mantle cell lymphoma cellsValeria Milani, Monika Lorenz, Marc Weinkauf, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|January 28, 2004
Use of polymorphisms in the noncoding region of the human mitochondrial genome to identify potential contamination of human leukemia-lymphoma cell linesGrit Hutter, Christina Nickenig, Henk Garritsen, et al.
Hemasphere|April 5, 2024
Precision hematology: Navigating the evolution of diagnostic classifications in the era of globalized medicineElizabeth Macintyre, Konstanze Döhner, Kirsten Grønbæk, et al.
Thrombosis and Haemostasis|October 9, 2008
Successful salvage treatment of chronic refractory immune thrombocytopenia using a simplified method to generate vincristine-loaded plateletsOliver Weigert, Georg Wittmann, Stefanie Gruetzner, et al.
Hemasphere|October 17, 2025
Patient-centered and proportionate safety reporting in clinical trials facilitates evidence-based medicine for the benefit of patients and society: An EHA priorityTarec Christoffer El-Galaly, Ananda Plate, Gita Thanarajasingam, et al.
Annals of Hematology|March 30, 2016
Altered treatment of chronic lymphocytic leukemia in Germany during the last decadeAnna-Katharina Zoellner, Thomas Höhler, Stefan Fries, et al.
Annals of Hematology|September 2, 2025
Follicular lymphoma or diffuse large B-cell lymphoma: a population based analysis of epidemiological and health economic aspects in GermanyKarin Berger, Bernhard Moertl, Michael von Bergwelt-Baildon, et al.
Pageof 34

Showing results (91-100 of 336) with videos related to

Sort By:
Pageof 34
Leukemia & Lymphoma|May 7, 2015
Advances and issues in mantle cell lymphoma research: report of the 2014 Mantle Cell Lymphoma Consortium WorkshopBrad S Kahl, Leo I Gordon, Martin Dreyling, et al.
European Journal of Haematology|June 11, 2014
Severe cytokine release syndrome after the first dose of Brentuximab Vedotin in a patient with relapsed systemic anaplastic large cell lymphoma (sALCL): a case report and review of literatureStefan K Alig, Martin Dreyling, Bettina Seppi, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 10, 2008
A polyvalent cellular vaccine induces T-cell responses against specific self-antigens overexpressed in chronic lymphocytic B-cell leukemiaKonrad Kronenberger, Elfriede Nössner, Bernhard Frankenberger, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|August 12, 2009
Combination of hyperthermia and bortezomib results in additive killing in mantle cell lymphoma cellsValeria Milani, Monika Lorenz, Marc Weinkauf, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|January 28, 2004
Use of polymorphisms in the noncoding region of the human mitochondrial genome to identify potential contamination of human leukemia-lymphoma cell linesGrit Hutter, Christina Nickenig, Henk Garritsen, et al.
Hemasphere|April 5, 2024
Precision hematology: Navigating the evolution of diagnostic classifications in the era of globalized medicineElizabeth Macintyre, Konstanze Döhner, Kirsten Grønbæk, et al.
Thrombosis and Haemostasis|October 9, 2008
Successful salvage treatment of chronic refractory immune thrombocytopenia using a simplified method to generate vincristine-loaded plateletsOliver Weigert, Georg Wittmann, Stefanie Gruetzner, et al.
Hemasphere|October 17, 2025
Patient-centered and proportionate safety reporting in clinical trials facilitates evidence-based medicine for the benefit of patients and society: An EHA priorityTarec Christoffer El-Galaly, Ananda Plate, Gita Thanarajasingam, et al.
Annals of Hematology|March 30, 2016
Altered treatment of chronic lymphocytic leukemia in Germany during the last decadeAnna-Katharina Zoellner, Thomas Höhler, Stefan Fries, et al.
Annals of Hematology|September 2, 2025
Follicular lymphoma or diffuse large B-cell lymphoma: a population based analysis of epidemiological and health economic aspects in GermanyKarin Berger, Bernhard Moertl, Michael von Bergwelt-Baildon, et al.
Pageof 34